Vardhman Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 25-07-2024
- Company Age 30 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.90 M
as on 25-07-2024
- Satisfied Charges ₹ 5.00 M
as on 25-07-2024
- Revenue 1.24%
(FY 2023)
- Profit -0.09%
(FY 2023)
- Ebitda -6.11%
(FY 2023)
- Net Worth 9.19%
(FY 2023)
- Total Assets 8.81%
(FY 2023)
About Vardhman Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹6.90 M. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Atri, Premlata Atri, Poonam Jain, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1994PTC062939
- Company No.
062939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vardhman Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Jain  | Managing Director | 28-Sep-2006 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Atri | Whole-Time Director | 29-Apr-2005 | Current |
| Premlata Atri | Director | 29-Apr-2005 | Current |
| Poonam Jain | Director | 26-Jun-2006 | Current |
| Palash Jain | Director | 16-Mar-2012 | Current |
| Deo Mishra | Director | 18-Nov-2014 | Current |
Financial Performance and Corporate Structure Insights of Vardhman Diagnostics.
Vardhman Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.24% increase. The company also saw a slight decrease in profitability, with a 0.09% decrease in profit. The company's net worth moved up by a moderate rise of 9.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vardhman Diagnostics?
In 2022, Vardhman Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 28 Sep 2015 | ₹6.90 M | Open |
Punjab National Bank Creation Date: 04 Dec 2014 | ₹5.00 M | Satisfied |
How Many Employees Work at Vardhman Diagnostics?
Vardhman Diagnostics has a workforce of 18 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vardhman Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
